Carrie joined Sitryx from Cerevance where, as Chief Business Officer, she led portfolio strategy, business development and alliance management. Prior to this, Carrie served as Senior Vice President/Global Head of Business Development at CANbridge Pharmaceuticals Inc. and was Senior Director, Center of External Innovation at Takeda Pharmaceuticals, where she secured a number of research and development agreements. Carrie has also held various business development and commercial planning roles of increasing responsibility at EMD Serono Inc., Merck Serono SA, Novartis Pharma AG and Baxter Healthcare SA. She holds an MBA from INSEAD and a B.A. in Biotechnology from Duke University in Durham, NC.